Improved haemagglutinin antigen content in H5N1 candidate vaccine viruses with chimeric haemagglutinin molecules-Reference-Cited by-同舟云学术

Improved haemagglutinin antigen content in H5N1 candidate vaccine viruses with chimeric haemagglutinin molecules

Published:2010-11 Issue:50 Volume:28 Page:8008-8014
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Harvey Ruth,Nicolson Carolyn,Johnson Rachel E.,Guilfoyle Kate A.,Major Diane L.,Robertson James S.,Engelhardt Othmar G.

Funder

MRC grant

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference23 articles.

1. Antigenic and genetic characteristics of influenza A(H5N1) viruses and candidate vaccine viruses developed for potential use in human vaccines. September;World Health Organisation (WHO),2009

2. WHO. Website http://www.who.int/csr/disease/avian_influenza/en/index.html.

3. Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics;Subbarao;Virology,2003

4. Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system;Nicolson;Vaccine,2005

5. Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial;Bresson;The Lancet,2006

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-throughput sequencing-based neutralization assay reveals how repeated vaccinations impact titers to recent human H1N1 influenza strains;2024-03-09

2. Identification of the properties of H5 influenza vaccine viruses with high hemagglutinin yields;PLOS ONE;2023-01-20

3. Latent Cytomegalovirus Infection and Previous Capsular Polysaccharide Vaccination Predict Poor Vaccine Responses in Older Adults, Independent of Chronic Kidney Disease;Clinical Infectious Diseases;2021-03-16

4. Cell-Based Influenza A/H1N1pdm09 Vaccine Viruses Containing Chimeric Hemagglutinin with Improved Membrane Fusion Ability;Vaccines;2020-08-19

5. Segment 2 from influenza A(H1N1) 2009 pandemic viruses confers temperature-sensitive haemagglutinin yield on candidate vaccine virus growth in eggs that can be epistatically complemented by PB2 701D;Journal of General Virology;2019-07-01